
AI and Health: Discussing The New Perimeter of Decision-Making in Rome
Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.
Certified, auditable, and built for the European health data framework — from Europrivacy to ISO 27001.

Europrivacy
Art 42 GDPR
ISO 9001
Quality
ISO 27001
Information security

Gender Equality
UNI PDR 125:2022
NIST
Cybersecurity & privacy
Synthetic data enables institutions and healthcare organizations to forecast demand, model scenarios, measure performance, and generate evidence for better decisions. Insights can be shared across organizations without exposing patient-level data.
Learn moreHigh-quality synthetic cohorts reflect real patient populations and are ready for analysis. They accelerate observational studies, outcomes research, and Real World Evidence generation while meeting regulatory requirements.
Learn moreSynthetic control arms can complement or replace traditional control groups using statistically robust foundations. By reducing recruitment needs, costs, and operational complexity, they make studies faster and more efficient.
Learn moreSpecialized clinical language models assist treatment comparison, medical reasoning, and knowledge access. Trained on real and synthetic data, they are designed for high-complexity healthcare environments.
Learn more



Overcome access delays, regulatory complexity, and unusable data. Aindo delivers reliable, instantly usable synthetic data so you can focus on decisions and discovery.
Explore our technologyResearchers & Clinicians
Access high-quality clinical evidence and insights without exposing identifiable patient data.
Pharma & CROs
Generate analysis-ready synthetic data to accelerate studies, RWE, and clinical development while reducing time and cost.
Public Administration
Forecast demand, capacity, and system scenarios with reliable and scalable synthetic populations.

Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.

Aindo and IQVIA Italy join forces to scale synthetic data adoption in the Italian healthcare ecosystem.

Under the patronage of Regione Lombardia, Aindo gathered leading IRCCS directors, pharma leaders, and institutions to shape the future of AI in healthcare.



















































